Spots Global Cancer Trial Database for Analysis of Survival Status of KRAS Mutation Advanced Non-small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Analysis of Survival Status of KRAS Mutation Advanced Non-small Cell Lung Cancer
Official Title: Analysis of Survival Status of KRAS Mutation Advanced Non-small Cell Lung Cancer Based on NGS Test Results in Hunan Province, China
Study ID: NCT03647098
Interventions
Study Description
Brief Summary: This study aims to analyze the survival condition of different groups about non-small cell lung cancer patients with KRAS mutations. These groups are made according to the treatment regime, brain metastases and KRAS alterations.
Detailed Description: This study aims to analyze the survival condition of different groups about non-small cell lung cancer patients with KRAS mutations. These groups are made according to the treatment regime, brain metastases and KRAS alterations. All the groups were assessed to chemotherapy, chemotherapy plus immunotherapy, clinical trials etc.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hunan Cancer Hospital, Changsha, Hunan, China
Contact Details
Name: Yongchang Zhang, MD
Affiliation: zhangyongchang@csu.edu.cn
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
